Evolus, Inc. (EOLS)

USD 9.48

(0.69%)

Net Debt Summary of Evolus, Inc.

  • Evolus, Inc.'s latest annual net debt in 2023 was 63.7 Million USD , up 230.49% from previous year.
  • Evolus, Inc.'s latest quarterly net debt in 2024 Q1 was 29.69 Million USD , down -53.39% from previous quarter.
  • Evolus, Inc. reported annual net debt of 19.27 Million USD in 2022, up 126.96% from previous year.
  • Evolus, Inc. reported annual net debt of -71.51 Million USD in 2021, down -300.01% from previous year.
  • Evolus, Inc. reported quarterly net debt of 33.08 Million USD for 2024 Q2, up 11.41% from previous quarter.
  • Evolus, Inc. reported quarterly net debt of 56.4 Million USD for 2023 Q3, up 2.34% from previous quarter.

Annual Net Debt Chart of Evolus, Inc. (2023 - 2015)

Historical Annual Net Debt of Evolus, Inc. (2023 - 2015)

Year Net Debt Net Debt Growth
2023 63.7 Million USD 230.49%
2022 19.27 Million USD 126.96%
2021 -71.51 Million USD -300.01%
2020 35.75 Million USD 367.91%
2019 -13.34 Million USD 82.5%
2018 -76.25 Million USD -136.09%
2017 211.32 Million USD 254.73%
2016 59.57 Million USD 41.28%
2015 42.16 Million USD 0.0%

Peer Net Debt Comparison of Evolus, Inc.

Name Net Debt Net Debt Difference
Bright Green Corporation 1.84 Million USD -3359.15%
Alpha Teknova, Inc. 1.97 Million USD -3127.356%
ANI Pharmaceuticals, Inc. 94.2 Million USD 32.374%
Aquestive Therapeutics, Inc. 74.95 Million USD 14.999%
Collegium Pharmaceutical, Inc. 435.33 Million USD 85.366%
Cosmos Health Inc. 8.59 Million USD -641.588%
Journey Medical Corporation -9.7 Million USD 756.175%
Embecta Corp. 1.31 Billion USD 95.144%
Esperion Therapeutics, Inc. 458.69 Million USD 86.111%
Dynavax Technologies Corporation 106.63 Million USD 40.256%
Intra-Cellular Therapies, Inc. -130.82 Million USD 148.696%
Pacira BioSciences, Inc. 432.74 Million USD 85.278%
PainReform Ltd. -7.95 Million USD 901.358%
Sunshine Biopharma, Inc. -15.63 Million USD 507.48%
Sunshine Biopharma, Inc. -15.63 Million USD 507.48%
SCYNEXIS, Inc. -19.35 Million USD 429.24%
Safety Shot Inc -2.28 Million USD 2888.859%
China SXT Pharmaceuticals, Inc. -9.42 Million USD 775.608%
Procaps Group, S.A. 242.93 Million USD 73.775%
Theratechnologies Inc. 24.87 Million USD -156.154%
Harrow Health, Inc. 116.41 Million USD 45.276%
Sonoma Pharmaceuticals, Inc. -2.52 Million USD 2628.095%
Biofrontera Inc. 4.05 Million USD -1470.71%
DURECT Corporation -7.65 Million USD 932.349%
Supernus Pharmaceuticals, Inc. -33.52 Million USD 290.02%
Cronos Group Inc. -663.32 Million USD 109.604%
OptiNose, Inc. 58.06 Million USD -9.718%
Ironwood Pharmaceuticals, Inc. 623.38 Million USD 89.78%
Kala Pharmaceuticals, Inc. -14.57 Million USD 537.195%
RedHill Biopharma Ltd. -5.18 Million USD 1328.454%
Organogenesis Holdings Inc. 15.01 Million USD -324.352%
Guardion Health Sciences, Inc. -6.35 Million USD 1101.754%
Cumberland Pharmaceuticals Inc. 106.85 Thousand USD -59518.75%
Radius Health, Inc. 359.28 Million USD 82.268%
Universe Pharmaceuticals INC 197.2 Thousand USD -32204.814%
ProPhase Labs, Inc. 19.23 Million USD -231.278%
Phibro Animal Health Corporation 454.84 Million USD 85.994%
Procaps Group S.A. 242.93 Million USD 73.775%
Alvotech 1.06 Billion USD 94.014%
TherapeuticsMD, Inc. 3.67 Million USD -1632.137%
Viatris Inc. 17.13 Billion USD 99.628%
Rockwell Medical, Inc. 4.45 Million USD -1329.713%
Aytu BioPharma, Inc. -4.87 Million USD 1406.295%
SIGA Technologies, Inc. -148.68 Million USD 142.849%
Tilray Brands, Inc. 158.97 Million USD 59.926%
Lifecore Biomedical, Inc. 121.89 Million USD 47.737%
Shineco, Inc. 29.29 Million USD -117.505%
PetIQ, Inc. 351.93 Million USD 81.898%
Regencell Bioscience Holdings Limited -2.9 Million USD 2295.746%
Incannex Healthcare Limited -5.48 Million USD 1261.495%
Neurocrine Biosciences, Inc. 177.3 Million USD 64.068%
Alimera Sciences, Inc. 55.3 Million USD -15.186%
Silver Spike Investment Corp. -32.61 Million USD 295.354%
Assertio Holdings, Inc. -32.52 Million USD 295.85%
Shuttle Pharmaceuticals Holdings, Inc. -1.48 Million USD 4379.375%
Petros Pharmaceuticals, Inc. -5.06 Million USD 1358.956%
Clever Leaves Holdings Inc. -4.81 Million USD 1423.39%
Cyclo Therapeutics, Inc. -8.21 Million USD 875.652%
Avadel Pharmaceuticals plc 4.21 Million USD -1410.742%
Hempacco Co., Inc. 13.61 Million USD -367.936%
Talphera, Inc. -5.72 Million USD 1213.582%
Alvotech 1.06 Billion USD 94.014%
Eagle Pharmaceuticals, Inc. 7.14 Million USD -791.645%
Lantheus Holdings, Inc. -96.71 Million USD 165.875%
Currenc Group, Inc. -16.57 Million USD 484.405%
Kamada Ltd. -46.43 Million USD 237.209%
Indivior PLC -33.95 Million USD 287.641%
Evoke Pharma, Inc. 260.57 Thousand USD -24349.101%
Flora Growth Corp. -713 Thousand USD 9035.203%
Cyclo Therapeutics, Inc. -8.21 Million USD 875.652%
HUTCHMED (China) Limited -197.45 Million USD 132.264%
Amphastar Pharmaceuticals, Inc. 479.11 Million USD 86.703%
Akanda Corp. 3.9 Million USD -1531.482%